Kitchology, a food+wellness+tech startup headquartered in Germantown, was among the winners of this year’s Maryland Incubator Company of the Year (ICOY) Awards, winning in the consumer product category.
QIAGEN N.V. (Nasdaq: QGEN) announced the successful completion of the conditional, voluntary public tender offer for the shares in Exiqon A/S, a world leader in RNA technology. The extended Offer Period expired yesterday, on 22 June 2016, at 23.59 (CET).
Another week, another new initiative for IBM Watson Health.
Wednesday, IBM announced the formation of a Watson Health medical imaging collaborative, seeking to make “cognitive imaging” a routine part of medical practice in oncology, neurology, diabetes care, eye care, cardiovascular disease and other image-heavy specialties. “Imaging is one of the things that spans across many different areas,” said Anne Le Grand, IBM Watson Health’s vice president of imaging.
Between June 2015 and June 2016, we’ve created more spaces and places for people to engage with the Science Center; honed and expanded our programs to support innovation and entrepreneurship; and enhanced the way we talk about our role in Greater Philadelphia’s innovation ecosystem.
Join us for a thrilling evening of start-up pitches from multiple sectors in healthcare including: Services, Health IT, Biotechnology, Medical Devices and Diagnostics. Applications are still being accepted, so if you not afraid of getting nipped by one of our judges, send your information to jhausfeld@sopenet.org.
The University System of Maryland is hoping a new $25 million venture capital fund it established will help spin off more commercial businesses — with the system reaping the benefits in the long run.
Qiagen and CosmosID have joined the Metagenomics and Metadesign of Subways and Urban Biomes (MetaSUB) consortium, an international five-year effort led by Weill Cornell Medicine, to map the genomes and epigenomes of microbial communities in 54 cities in 32 countries.
The first proposed test of CRISPR gene-editing technology in human beings is being funded by Internet billionaire Sean Parker, MIT Technology Review has learned.
The novel cancer treatment, initially disclosed last week, is being reviewed Tuesday by a federal advisory panel in Washington, D.C., and could become the first clinical trial involving CRISPR, the red-hot gene modification technology.
Innovation Village forges partnership with socially conscious incubator – Baltimore Business Journal
Innovation Village, an effort to spur economic development in West Baltimore, is partnering with Howard County’s Conscious Venture Lab to help develop fledgling companies and entrepreneurs.
When David R. Tabatadze’s small biotechnology venture ran out of money in 2013, he almost gave up on it.
He went to pharmaceutical companies and “angel” investors, those individuals willing to put modest amounts of money into new businesses. None were interested in funding his research into potential genetic medicines.